Industry Sponsored Symposium

Friday, March 4, 2022
12:30 PM – 1:00 PM
Grand Ballroom Salon D-H

Histological Improvements in VVA Patients with Intravaginal Prasterone (Intrarosa®): What do Aromatase Inhibitors Tell Us?
Intravaginal prasterone has been shown to reduce moderate to severe dyspareunia in postmenopausal patients. This presentation will not only offer an unprecedented insight into the histological improvements underlying the relief of these symptoms by Intrarosa®, but also investigate a potential role for androgens in the physiopathology of VVA.


Alain Dury 150

Alain Dury, PhD
Director, Scientific Affairs & Alliance Manager, Endoceutics, Inc.

ISSWSH Fall Course 2024
November 7-10, 2024
169 days left
DoubleTree Resort - Paradise Valley - Scottsdale, AZ
Visit the Course Website

ISSWSH/ISSM Joint Meeting 2025
February 27 - March 2, 2025
279 days left
Grand Hyatt Atlanta - Atlanta, GA
Visit the Meeting Website

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.